Evidence map›Paper›PMID 30475591›Full record

ArticleBioconjugate chemistry2019

Activatable Near-Infrared Fluorescence Imaging Using PEGylated Bacteriochlorin-Based Chlorin and BODIPY-Dyads as Probes for Detecting Cancer.

Fusa Ogata, Tadanobu Nagaya, Yasuhiro Maruoka, Joshua Akhigbe, Adam Meares, Melissa Y Lucero, Andrius Satraitis, Daiki Fujimura, Ryuhei Okada, Fuyuki Inagaki and 3 more

Open access · greenAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Development and Validation of Nerve-Targeted Bacteriochlorin Sensors.Journal of the American Chemical Society · 2023
    Article
  3. Article
  4. BFMolecules (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Leveraging synthetic chlorins for bio-imaging applications.Chemical communications (Cambridge, England) · 2020
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Fusa OgataMolecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.
Tadanobu NagayaMolecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.
Yasuhiro MaruokaMolecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.
Joshua AkhigbeDepartment of Chemistry and Biochemistry , University of Maryland, Baltimore County , Baltimore , Maryland 21250 United States of America.
Adam MearesDepartment of Chemistry and Biochemistry , University of Maryland, Baltimore County , Baltimore , Maryland 21250 United States of America.
Melissa Y LuceroDepartment of Chemistry and Biochemistry , University of Maryland, Baltimore County , Baltimore , Maryland 21250 United States of America.
Andrius SatraitisDepartment of Chemistry and Biochemistry , University of Maryland, Baltimore County , Baltimore , Maryland 21250 United States of America.
Daiki FujimuraMolecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.
Ryuhei OkadaMolecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.
Fuyuki InagakiMolecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.
Peter L ChoykeMolecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.
Marcin PtaszekDepartment of Chemistry and Biochemistry , University of Maryland, Baltimore County , Baltimore , Maryland 21250 United States of America.ORCID 0000-0001-6468-6900
Hisataka KobayashiMolecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.ORCID 0000-0003-1019-4112
National Institutes of Health · USUniversity of Maryland, Baltimore County · US

Funding

Activatable molecular cancer imaging probeZIABC011512 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KOBAYASHI, HISATAKA · 2013 to 2025
$2.7M
Novel Activatable Fluorophores for Multicolor Fluorescence-Guided Cancer SurgeryU01CA181628 · NCI · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI PTASZEK, MARCIN · 2014 to 2016
$589k
Intramural NIH HHS ZIA BC011512NCI NIH HHS U01 CA181628
6 · The paper itself

Abstract

Near infrared (NIR) fluorescent probes are attractive tools for biomedical in vivo imaging due to the relatively deeper tissue penetration and lower background autofluorescence. Activatable probes are turned on only after binding to their target, further improving target to background ratios. However, the number of available activatable NIR probes is limited. In this study, we introduce two types of activatable NIR fluorophores derived from bacteriochlorin: chlorin-bacteriochlorin energy-transfer dyads and boron-dipyrromethene (BODIPY)-bacteriochlorin energy-transfer dyads. These fluorophores are characterized by multiple narrow excitation bands with relatively strong emission in the NIR. Targeted bacteriochlorin-based antibody or peptide probes have been previously limited by aggregation after conjugation. Polyethylene glycol (PEG) chains were added to improve the hydrophilicity without altering pharmacokinetics of the targeting moieties. These PEGylated bacteriochlorin-based activatable fluorophores have potential as targeted activatable, multicolor NIR fluorescent probes for in vivo applications.

Indexed as

AnimalsAntibodies, MonoclonalBoron CompoundsCell Line, TumorFluorescent DyesHeterograftsHumansMiceNeoplasmsOptical ImagingPolyethylene GlycolsPorphyrins4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneAntibodies, MonoclonalbacteriochlorinBoron CompoundsFluorescent DyesPolyethylene GlycolsPorphyrins

Identifiers

PMID30475591
PMCPMC7307181
OpenAlexW2902698738

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.